Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

A patient with complete hair loss regrew all her hair using tofacitinib.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Adalimumab improved folliculitis decalvans in most patients.

A new microneedle system effectively delivers a vasodilator to hair follicles, promoting hair growth better than current treatments.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Nilotinib may cause gray hair to return to its original color.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Vijaya successfully fought stage 2A breast cancer with surgery, chemotherapy, radiotherapy, and hormone therapy, while advocating for support groups.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.